Effect of erythropoietin on the migration of bone marrow-derived mesenchymal stem cells to the acute kidney injury microenvironment

Experimental Cell Research

Volumn 319, Issue 13, 2013, Pages 2019-2027

  Liu, Nanmei ^a,b   Tian, Jun ^b   Cheng, Jin ^b   Zhang, Jinyuan ^b  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b The 455th Hospital of PLA   (China)

Author keywords

Acute kidney injury; Bone marrow derived mesenchymal stem cells; Erythropoietin; Hypoxia re oxygenation; Migration

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; ERYTHROPOIETIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; STROMAL CELL DERIVED FACTOR 1;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CHEMOTAXIS; DRUG MECHANISM; IN VITRO STUDY; IN VIVO STUDY; KIDNEY FUNCTION; KIDNEY PARENCHYMA; KIDNEY TUBULE EPITHELIUM; MESENCHYMAL STEM CELL; MICROENVIRONMENT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REOXYGENATION;

MUS;

EID: 84879882648     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2013.04.008     Document Type: Article

References (35)

1. Yeagy B.A., Cherqui S. Kidney repair and stem cells: a complex and controversial process. Pediatr. Nephrol. 2011, 26:1427-1434.
2. Chhabra P., Brayman K.L. The use of stem cells in kidney disease. Curr. Opinion Organ Transplant. 2009, 14:72-78.
3. Ponte A.L., Marais E., Gallay N., Langonné A., Delorme B., Hérault O., Charbord P., Domenech J. The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities. Stem Cell 2007, 25:1737-1745.
4. Tögel F., Isaac J., Hu Z., Weiss K., Westenfelder C. Renal SDF-1 signals mobilization and homing of CXCR4-positive cells to the kidney after ischemic injury. Kidney Int. 2005, 67:1772-1784.
5. Herrera M.B., Bussolati B., Bruno S., Fonsato V., Romanazzi G.M., Camussi G. Mesenchymal stem cells contribute to the renal repair of acute tubular epithelial injury. Int. J. Mol. Med. 2004, 14:1035-1041.
6. Morigi M., Imberti B., Zoja C., Corna D., Tomasoni S., Abbate M., Rottoli D., Angioletti S., Benigni A., Perico N., Alison M., Remuzzi G. Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure. J. Am. Soc. Nephrol. 2004, 15:1794-1804.
7. Rjiba-Touati K., Ayed-Boussema I., Belarbia A., Achour A., Bacha H. Protective effect of recombinant human erythropoietin against cisplatin-induced oxidative stress and nephrotoxicity in rat kidney. Int. J. Toxicol. 2011, 30:510-517.
8. Yang F.L., Subeq Y.M., Chiu Y.H., Lee R.P., Lee C.J., Hsu B.G. Recombinant human erythropoietin reduces rhabdomyolysis-induced acute renal failure in rats. Injury 2012, 43:367-373.
9. Song Y.R., Lee T., You S.J., Chin H.J., Chae D.W., Lim C., Park K.H., Han S., Kim J.H., Na K.Y. Prevention of acute kidney injury by erythropoietin in patients undergoing coronary artery bypass grafting: a pilot study. Am. J. Nephrol. 2009, 30:253-260.
10. Zwezdaryk K.J., Coffelt S.B., Figueroa Y.G., Liu J., Phinney D.G., LaMarca H.L., Florez L., Morris C.B., Hoyle G.W., Scandurro A.B. Erythropoietin, a hypoxia-regulated factor, elicits a pro-angiogenic program in human mesenchymal stem cells. Exp. Hematol. 2007, 35:640-652.
11. Daga A., Muraglia A., Quarto R., Cancedda R., Corte G. Enhanced engraftment of EPO-transduced human bone marrow stromal cells transplanted in a 3D matrix in non-conditioned NOD/SCID mice. Gene Ther. 2002, 9:915-921.
12. Liu N.M., Tian J., Wang W.W., Cheng J., Hu D.Y., Zhang J.Y. Effects of mesenchymal stem cells on renal tubular epithelial cells apoptosis in mice under ischemia/reperfusion and its mechanism. Chin. J. Integrated Traditional West. Nephrol. 2010, 11:581-585.
13. N.M. Liu, G.F. Han, J. Cheng, J. Huang, J. Tian, Erythropoietin promotes the repair effect of acute kidney injury by bone-marrow mesenchymal stem cells transplantation, Exp. Biol. Med. (in press).
14. Chen J., Li Y., Wang L., Lu M., Zhang X., Chopp M. Therapeutic benefit of intracerebral transplantation of bone marrow stromal cells after cerebral ischemia in rats. J. Neurol. Sci. 2001, 189:49-57.
15. Barbash I.M., Chouraqui P., Baron J., Feinberg M.S., Etzion S., Tessone A., Miller L., Guetta E., Zipori D., Kedes L.H., Kloner R.A., Leor J. Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution. Circulation 2003, 108:863-868.
16. Devine S.M., Cobbs C., Jennings M., Bartholomew A., Hoffman R. Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates. Blood 2003, 101:2999-3001.
17. Yamaguchi J., Kusano K.F., Masuo O., Kawamoto A., Silver M., Murasawa S., Bosch-Marce M., Masuda H., Losordo D.W., Isner J.M., Asahara T. Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation 2003, 107:1322-1328.
18. Floridi F., Trettel F., Di Bartolomeo S., Ciotti M.T., Limatola C. Signalling pathways involved in the chemotactic activity of CXCL12 in cultured rat cerebellar neurons and CHP100 neuroepithelioma cells. J. Neuroimmunol. 2003, 135:38-46.
19. Horuk R. Chemokines beyond inflammation. Nature 1998, 393:524-525.
20. Li N., Lu X., Zhao X., Xiang F.L., Xenocostas A., Karmazyn M., Feng Q. Endothelial nitric oxide synthase promotes bone marrow stromal cell migration to the ischemic myocardium via upregulation of stromal cell-derived factor-1alpha. Stem Cells 2009, 27:961-970.
21. Lai P., Li T., Yang J., Xie C., Zhu X., Xie H., Ding X., Lin S., Tang S. Upregulation of stromal cell-derived factor 1 (SDF-1) expression in microvasculature endothelial cells in retinal ischemia-reperfusion injury. Graefes Arch. Clin. Exp. Ophthalmol. 2008, 246:1707-1713.
22. Ohnishi H., Mizuno S., Nakamura T. Inhibition of tubular cell proliferation by neutralizing endogenous HGF leads to renal hypoxia and bone marrow-derived cell engraftment in acute renal failure. Am. J. Physiol. Renal Physiol. 2008, 294:F326-335.
23. Ji J.F., He B.P., Dheen S.T., Tay S.S. Interactions of chemokines and chemokine receptors mediate the migration of mesenchymal stem cells to the impaired site in the brain after hypoglossal nerve injury. Stem Cells 2004, 22:415-427.
24. Wang Y., Deng Y., Zhou G.Q. SDF-1α/CXCR4-mediated migration of systemically transplanted bone marrow stromal cells towards ischemic brain lesion in a rat model. Brain Res. 2008, 1195:104-112.
25. Wynn R.F., Hart C.A., Corradi-Perini C., O'Neill L., Evans C.A., Wraith J.E., Fairbairn L.J., Bellantuono I. A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow. Blood 2004, 104:2643-2645.
26. Li M., Yu J., Li Y., Li D., Yan D., Qu Z., Ruan Q. CXCR4 positive bone mesenchymal stem cells migrate to human endothelial cell stimulated by ox-LDL via SDF-1 alpha/CXCR4 signaling axis. Exp. Mol. Pathol. 2010, 88:250-255.
27. Lin J.S., Chen Y.S., Chiang H.S., Ma M.C. Hypoxic preconditioning protects rat hearts against ischaemia-reperfusion injury: role of erythropoietin on progenitor cell mobilization. J. Physiol. 2008, 586:5757-5769.
28. Klopsch C., Furlani D., Gäbel R., Li W., Pittermann E., Ugurlucan M., Kundt G., Zingler C., Titze U., Wang W., Ong L.L., Wagner K., Li R.K., Ma N., Steinhoff G. Intracardiac injection of erythropoietin induces stem cell recruitment and improves cardiac functions in a rat myocardial infarction model. J. Cell. Mol. Med. 2009, 13:664-679.
29. Brunner S., Winogradow J., Huber B.C., Zaruba M.M., Fischer R., David R., Assmann G., Herbach N., Wanke R., Mueller-Hoecker J., Franz W.M. Erythropoietin administration after myocardial infarction in mice attenuates ischemic cardiomyopathy associated with enhanced homing of bone marrow-derived progenitor cells via the CXCR-4/SDF-1 axis. FASEB J. 2009, 23:351-361.
30. Spandou E., Tsouchnikas I., Karkavelas G., Dounousi E., Simeonidou C., Guiba-Tziampiri O., Tsakiris D. Erythropoietin attenuates renal injury in experimental acute renal failure ischaemic/reperfusion model. Nephrol. Dial. Transplant. 2006, 21:330-336.
31. Barbero S., Bonavia R., Bajetto A., Porcile C., Pirani P., Ravetti J.L., Zona G.L., Spaziante R., Florio T., Schettini G. Stromal cell-derived factor 1alpha stimulates human glioblastoma cell growth through the activation of both extracellular signal-regulated kinases 1/2 and Akt. Cancer Res. 2003, 63:1969-1974.
32. Bobis-Wozowicz S., Miekus K., Wybieralska E., Jarocha D., Zawisz A., Madeja Z., Majka M. Genetically modified adipose tissue-derived mesenchymal stem cells overexpressing CXCR4 display increased motility, invasiveness, and homing to bone marrow of NOD/SCID mice. Exp. Hematol. 2011, 39:686-696.
33. Dimmeler S., Aicher A., Vasa M., Mildner-Rihm C., Adler K., Tiemann M., Rütten H., Fichtlscherer S., Martin H., Zeiher A.M. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J. Clin. Invest. 2001, 108:391-397.
34. Kollet O., Shivtiel S., Chen Y.Q., Suriawinata J., Thung S.N., Dabeva M.D., Kahn J., Spiegel A., Dar A., Samira S., Goichberg P., Kalinkovich A., Arenzana-Seisdedos F., Nagler A., Hardan I., Revel M., Shafritz D.A., Lapidot T. HGF, SDF-1, and MMP-9 are involved in stress-induced human CD34+ stem cell recruitment to the liver. J. Clin. Invest. 2003, 112:160-169.
35. Neuss S., Schneider R.K., Tietze L., Knüchel R., Jahnen-Dechent W. Secretion of fibrinolytic enzymes facilitates human mesenchymal stem cell invasion into fibrin clots. Cells Tissues Organs 2010, 191:36-46.